tap.info.tn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tap.info.tn Daily Mail and Mail on Sunday newspapers.
AstraZeneca announces that results from a Phase III pre-exposure prophylaxis trial against COVID-19 showed that AstraZeneca s sipavibart , an investigational long-acting antibody , demonstrated a.
AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.
The Cambridge, England-based pharmaceutical company announced that phase three.